Assure (NASDAQ:IONM – Get Rating) issued its quarterly earnings results on Monday. The company reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.13), MarketWatch Earnings reports. Assure had a negative return on equity of 11.57% and a negative net margin of 9.44%. During the same quarter in the prior year, the firm earned ($0.10) EPS.
NASDAQ IONM opened at $3.01 on Tuesday. The company has a market cap of $38.89 million, a PE ratio of -13.68 and a beta of 1.44. The company has a current ratio of 10.22, a quick ratio of 10.22 and a debt-to-equity ratio of 0.47. Assure has a 12 month low of $2.71 and a 12 month high of $11.35. The stock has a 50 day moving average of $5.11 and a 200-day moving average of $5.25.
Several research firms have recently commented on IONM. Benchmark began coverage on Assure in a report on Tuesday, April 5th. They issued a “buy” rating and a $9.00 price objective for the company. Zacks Investment Research raised Assure from a “sell” rating to a “hold” rating in a report on Thursday, January 20th.
Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services primarily associated with spine and head surgeries. It delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing services to support surgeons and medical facilities during invasive procedures.
- Get a free copy of the StockNews.com research report on Assure (IONM)
- VMWare Inc: Strong Revenues and Excellent Potential
- Etsy Buy!: Why Etsy Stock is Making a Crafty Comeback
- FIGS, Inc Moves Lower On Analysts’ Downgrades
- MarketBeat Podcast: Trading Volatile Markets While Preserving Capital
- Option Care Health Stock is Making a Healthy Pullback
Receive News & Ratings for Assure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assure and related companies with MarketBeat.com's FREE daily email newsletter.